Martin Scherer (original) (raw)

From Wikipedia, the free encyclopedia

German physician

Martin Scherer (* born 27 July 1972 in Marburg) is a German university professor and specialist for general practice and primary care. He is director of the Department of General practice and Primary care and head of the Division of Primary Medical Care at the University Medical Center Hamburg-Eppendorf.[1] Since 2019 president of the German College of General Practitioners and Family Physicians (DEGAM) and since 2006 speaker of the Clinical Guidelines Committee.[2]

Scherer underwent his medical education in Marburg, Vienna and Paris from 1993 to 1999, and after completing his training as a specialist in General Practice and Primary Care in 2004, he worked as a researcher in the Department of General Practice and Primary Care at the University of Göttingen until 2009, from 2006 as a senior physician. In 2009, Scherer was appointed to the W2 professorship ‘Health Services Research and its Methods’ as deputy director at the Institute of Social Medicine at the University of Lübeck.[3][ Also in 2009, he was a founding member and deputy spokesperson of the Academic Centre for Population Medicine and Health Services Research.[4] Since 2011, Scherer has been Director of the Institute and Polyclinic of General Practice and Primary Care, University Medical Center Hamburg. [5] From 2015 to 2020, he was also editor of the Hamburger Ärzteblatt. [6] Since 2020, he has been co-host of the podcast ‘EvidenzUpdate’ of the Ärztezeitung, which deals with the classification of new scientific evidence for clinical practice.[7] In 2019, Martin Scherer (Hamburg) was elected President of the DEGAM. [8]He succeeded Erika Baum (Marburg), who was honoured with the Federal Cross of Merit in 2023 for her commitment to general practice.[9] Eva Hummers and Jean-François Chenot have been Vice Presidents since 2019. During his presidency, Martin Scherer has championed the topics of digitalisation, climate change and health in general practice, among others. Two corresponding DEGAM sections were founded in 2022. In 2023, under the leadership of Martin Scherer, DEGAM presented ten ‘Lessons learned from the pandemic’ and thus developed recommendations to make the German healthcare system more resilient in the face of future pandemics.[10] Since June 2024, Scherer has also been the spokesperson for the Centre for Health Care Research & Public Health at the UKE.[11]

Scientific contribution

[edit]

One focus of Scherer's scientific work is the development of quality indicators in the context of healthcare research methods. The aim here is the measurability of quality in healthcare with the help of quality indicators that are developed for this purpose.[12] Scherer also worked on systematic reviews and meta-analyses. [13][14][15] As spokesperson for the DEGAM's permanent guideline commission, Scherer was involved in the development of guidelines. Another focus of Scherer's work is multimorbidity.[16][17][18] As part of the Chronic Disease Score study, a multimorbidity index was developed and validated that can be used to assess the disease burden of chronically ill patients in Germany based on medication data. In his role as Co-Principal Investigator (Co-PI), Scherer, together with Hendrik van den Bussche (Principal Investigator), developed the MultiCare Claims Study funded by the Federal Ministry of Education and Research (BMBF). This addressed the question of whether the approach according to which individual illnesses and their interactions are more relevant for multimorbidity or whether it is less the illnesses and more the subjective consequences for the patient. Also in the role of co-principal investigator, Scherer worked together with Wolfgang Maier on the AgeCoDe study for dementia[19][20] and was principal investigator of the RECODE study for heart failure.[21]

Finally, Scherer deals with overuse, underuse and target supply. During the Covid pandemic, he worked on important questions regarding vaccination readiness,[22] the nocebo effect,[23] consequences for the care system[24][25][26][27] and the management of chronic diseases.[28][29] As co-PI of the GETFEEDBACK-GP study, Scherer, together with Bernd Löwe (Principal Investigator), was able to publish a high-ranking RCT on depression screening and subsequent feedback procedures in general practice.[30] Martin Scherer's scientific oeuvre comprises over 400 Medline-listed publications.[31]

Memberships in scientific organisations

[edit]

2009 and 2018 Dr. Lothar Beyer Award for research in General Practice and Primary Care

PubMed List of Publications

  1. ^ "Institute for Primary Care-English Website".
  2. ^ "Martin Scherer, Spokesman for the Standing Committee of DEGAM". Archived from the original on 2017-11-10. Retrieved 2016-05-30.
  3. ^ "2024: Universität zu Lübeck". www.uni-luebeck.de. Retrieved 2024-08-24.
  4. ^ "ZBV: ZBV". www.zbv.uni-luebeck.de. Retrieved 2024-08-24.
  5. ^ "UKE - Department of General Practice and Primary Care". www.uke.de. Retrieved 2024-08-24.
  6. ^ "Martin Scherer retires as main editor of the Hamburger Ärtzteblatt" (PDF).
  7. ^ "' EvidenzUpdate' with Martin Scherer".
  8. ^ "Martin Scherer elected as president of DEGAM". 11 October 2019.
  9. ^ "Erika Baum Federal Cross of Merit". 17 October 2023.
  10. ^ "'Lessons learned' from the Covid-19 pandemic in germany" (PDF).
  11. ^ "UKE - Center for Health Care Research - CHCR". www.uke.de. Retrieved 2024-08-24.
  12. ^ Herzberg, H.; Bernateck, K.; Welti, F.; Joos, S.; Pohontsch, N.; Blozik, E.; Scherer, M. (2015-05-07). "Patientenbeteiligung bei der Entwicklung von Qualitätsindikatoren am Beispiel der Nationalen VersorgungsLeitlinie Chronische Herzinsuffizienz – Eine qualitative Analyse kollektiver Sichtweisen". Das Gesundheitswesen. 78 (6): 373–377. doi:10.1055/s-0035-1548880. ISSN 0941-3790. PMID 25951114.
  13. ^ Kötter, T.; Da Costa, B. R.; Fässler, M.; Blozik, E.; Linde, K.; Jüni, P.; Reichenbach, S.; Scherer, M. (2015). "Kötter T, da Costa BR, Fässler M, Blozik E, Linde K, Jüni P, Reichenbach S, Scherer M. Metamizole-associated adverse events: a systematic review and meta-analysis. PLoS One. 2015 Apr 13;10(4):e0122918. doi: 10.1371/journal.pone.0122918. PMID: 25875821; PMCID: PMC4405027". PLOS ONE. 10 (4): e0122918. doi:10.1371/journal.pone.0122918. PMC 4405027. PMID 25875821.
  14. ^ Nüesch, E.; Trelle, S.; Reichenbach, S.; Rutjes, A. W.; Bürgi, E.; Scherer, M.; Altman, D. G.; Jüni, P. (2009). "Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Bürgi E, Scherer M, Altman DG, Jüni P. The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ. 2009 Sep 7;339:b3244. doi: 10.1136/bmj.b3244. PMID: 19736281; PMCID: PMC2739282". BMJ (Clinical Research Ed.). 339: b3244. doi:10.1136/bmj.b3244. PMC 2739282. PMID 19736281.
  15. ^ "Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, Dieppe PA, Jüni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007 Apr 17;146(8):580-90. doi: 10.7326/0003-4819-146-8-200704170-00009. PMID: 17438317". doi:10.7326/0003-4819-146-8-200704170-00009.
  16. ^ Löffler, Christin; Altiner, Attila; Streich, Waldemar; Stolzenbach, Carl-Otto; Fuchs, Angela; Drewelow, Eva; Hornung, Anne; Feldmeier, Gregor; van den Bussche, Hendrik; Kaduszkiewicz, Hanna (2014-10-07). "Multimorbidität aus Hausarzt- und Patientensicht". Zeitschrift für Gerontologie und Geriatrie. 48 (5): 452–456. doi:10.1007/s00391-014-0820-9. ISSN 0948-6704. PMID 25287678.
  17. ^ von dem Knesebeck, O.; Döhner, H.; Kaduszkiewicz, H.; van den Bussche, H.; von Renteln Kruse, W. (February 2006). "Forschung zur Versorgung im höheren Lebensalter". Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 49 (2): 167–174. doi:10.1007/s00103-005-1213-4. ISSN 1436-9990.
  18. ^ Hansen, Heike; Pohontsch, Nadine; van den Bussche, Hendrik; Scherer, Martin; Schäfer, Ingmar (2015-06-02). "Reasons for disagreement regarding illnesses between older patients with multimorbidity and their GPs – a qualitative study". BMC Family Practice. 16 (1). doi:10.1186/s12875-015-0286-x. ISSN 1471-2296. PMC 4450605.
  19. ^ Roehr, Susanne; Luck, Tobias; Heser, Kathrin; Fuchs, Angela; Ernst, Annette; Wiese, Birgitt; Werle, Jochen; Bickel, Horst; Brettschneider, Christian; Koppara, Alexander; Pentzek, Michael; Lange, Carolin; Prokein, Jana; Weyerer, Siegfried; Mösch, Edelgard (2016-01-14). "Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly – Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe)". PLOS ONE. 11 (1): e0147050. Bibcode:2016PLoSO..1147050R. doi:10.1371/journal.pone.0147050. ISSN 1932-6203.
  20. ^ Heser, Kathrin; Wagner, Michael; Wiese, Birgitt; Prokein, Jana; Ernst, Annette; König, Hans-Helmut; Brettschneider, Christian; Riedel-Heller, Steffi G.; Luppa, Melanie; Weyerer, Siegfried; Eifflaender-Gorfer, Sandra; Bickel, Horst; Mösch, Edelgard; Pentzek, Michael; Fuchs, Angela (2014-12-10). "Associations between Dementia Outcomes and Depressive Symptoms, Leisure Activities, and Social Support". Dementia and Geriatric Cognitive Disorders Extra. 4 (3): 481–493. doi:10.1159/000368189. ISSN 1664-5464. PMC 4296229.
  21. ^ "UKE - Institut und Poliklinik für Allgemeinmedizin (IPA)". www.uke.de (in German). Retrieved 2024-08-24.
  22. ^ Wegwarth, Odette; Mansmann, Ulrich; Zepp, Fred; Lühmann, Dagmar; Hertwig, Ralph; Scherer, Martin (2023-02-16). "Vaccination Intention Following Receipt of Vaccine Information Through Interactive Simulation vs Text Among COVID-19 Vaccine–Hesitant Adults During the Omicron Wave in Germany". JAMA Network Open. 6 (2): e2256208. doi:10.1001/jamanetworkopen.2022.56208. ISSN 2574-3805. PMID 36795411.
  23. ^ Schäfer, Ingmar; Oltrogge, Jan Hendrik; Nestoriuc, Yvonne; Warren, Claire V.; Brassen, Stefanie; Blattner, Maximilian; Lühmann, Dagmar; Tinnermann, Alexandra; Scherer, Martin; Büchel, Christian (2023-03-27). "Expectations and Prior Experiences Associated With Adverse Effects of COVID-19 Vaccination". JAMA Network Open. 6 (3): e234732. doi:10.1001/jamanetworkopen.2023.4732. ISSN 2574-3805. PMC 10043751.
  24. ^ Schäfer, Ines; Haack, Alena; Neumann, Marie; Koch-Gromus, Uwe; Scherer, Martin; Petersen, Elina (March 2023). "Nichtinanspruchnahme medizinischer Leistungen in der COVID-19-Pandemie bei Personen mit chronischen Erkrankungen". Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (in German). 66 (3): 275–282. doi:10.1007/s00103-023-03665-9. ISSN 1436-9990. PMC 9891187.
  25. ^ Schäfer, Ingmar; Hansen, Heike; Menzel, Agata; Eisele, Marion; Tajdar, Daniel; Lühmann, Dagmar; Scherer, Martin (December 2021). "The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study". BMC Family Practice. 22 (1). doi:10.1186/s12875-021-01471-3. ISSN 1471-2296. PMC 8221278.
  26. ^ Eisele, Marion; Pohontsch, Nadine Janis; Scherer, Martin (2021-06-02). "Strategies in Primary Care to Face the SARS-CoV-2 / COVID-19 Pandemic: An Online Survey". Frontiers in Medicine. 8. doi:10.3389/fmed.2021.613537. ISSN 2296-858X. PMC 8206267. PMID 34150788.
  27. ^ Härter, Martin; Bremer, Daniel; Scherer, Martin; von dem Knesebeck, Olaf; Koch-Gromus, Uwe (September 2020). "Auswirkungen der COVID-19-Pandemie auf die klinische Versorgung, Arbeitsprozesse und Mitarbeitenden in der Universitätsmedizin: Ergebnisse einer Interviewstudie am UKE". Das Gesundheitswesen (in German). 82 (8/09): 676–681. doi:10.1055/a-1226-6828. ISSN 0941-3790. PMC 7516358.
  28. ^ Schäfer, Ingmar; Tajdar, Daniel; Walther, Laura; Bittner, Lasse; Lühmann, Dagmar; Scherer, Martin (2024-01-05). "Impact of two COVID-19 lockdowns on HbA1c levels in patients with type 2 diabetes and associations with patient characteristics: a multicentre, observational cohort study over three years". Frontiers in Public Health. 11. doi:10.3389/fpubh.2023.1272769. ISSN 2296-2565. PMC 10796585. PMID 38249413.
  29. ^ Tajdar, Daniel; Lühmann, Dagmar; Walther, Laura; Bittner, Lasse; Scherer, Martin; Schäfer, Ingmar (June 2024). "Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years". Diabetes Therapy. 15 (6): 1375–1388. doi:10.1007/s13300-024-01574-x. ISSN 1869-6953. PMC 11096287.
  30. ^ Löwe, Bernd; Scherer, Martin; Braunschneider, Lea-Elena; Marx, Gabriella; Eisele, Marion; Mallon, Tina; Schneider, Antonius; Linde, Klaus; Allwang, Christine; Joos, Stefanie; Zipfel, Stephan; Schulz, Sven; Rost, Liliana; Brenk-Franz, Katja; Szecsenyi, Joachim (April 2024). "Clinical effectiveness of patient-targeted feedback following depression screening in general practice (GET.FEEDBACK.GP): an investigator-initiated, prospective, multicentre, three-arm, observer-blinded, randomised controlled trial in Germany". The Lancet Psychiatry. 11 (4): 262–273. doi:10.1016/S2215-0366(24)00035-X. PMID 38432236.
  31. ^ "Martin Scherer - Search Results - PubMed". PubMed. Retrieved 2024-08-24.
  32. ^ AQUA- Institute on Applied Quality Improvement and Research in Healthcare
  33. ^ Versorgungsatlas of the Central Research Institute of Ambulatory Health Care
  34. ^ "DEGAM-Präsidium".
  35. ^ "CHCR-Website".
  36. ^ "Website of DESAM".
  37. ^ "Website of the Health Knowledge Board".